Derek Small
Direktor/Vorstandsmitglied bei INNOVIVA, INC.
Aktive Positionen von Derek Small
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INNOVIVA, INC. | Direktor/Vorstandsmitglied | 29.04.2024 | - |
Independent Dir/Board Member | 29.04.2024 | - | |
Luson Bioventures LLC
Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Gründer | 01.01.2007 | - |
Präsident | 01.01.2007 | - | |
Gate Neurosciences, Inc.
Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Gründer | 21.11.2018 | - |
Vorsitzender | 21.11.2018 | - | |
Direktor/Vorstandsmitglied | 21.11.2018 | - | |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Direktor/Vorstandsmitglied | 01.07.2017 | - |
Anagin, Inc.
Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Derek Small
Ehemalige bekannte Positionen von Derek Small
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 10.02.2015 | 11.06.2020 |
Vorstandsvorsitzender | 10.02.2015 | 06.08.2019 | |
Geschäftsführer | 01.07.2014 | 10.02.2015 | |
Finanzdirektor/CFO | 01.05.2019 | 06.08.2019 | |
Gründer | 01.07.2014 | 11.06.2020 | |
Präsident | 10.02.2015 | 06.08.2019 | |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Direktor/Vorstandsmitglied | 01.01.2009 | 01.04.2012 |
Vorstandsvorsitzender | 01.01.2009 | 01.04.2012 | |
Präsident | 01.01.2009 | 01.04.2012 | |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Vorstandsvorsitzender | 31.12.2008 | 30.06.2011 |
Präsident | 31.12.2008 | 30.06.2011 | |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Vorstandsvorsitzender | 01.10.2007 | 21.03.2009 |
Berater | 01.10.2007 | 21.03.2009 | |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Derek Small
Franklin College of Indiana, Inc. | Undergraduate Degree |
Harlaxton College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 7 |
Chief Executive Officer | 6 |
President | 6 |
Sektoral
Health Technology | 9 |
Finance | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
INNOVIVA, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
Simdesk Technologies, Inc.
Simdesk Technologies, Inc. Packaged SoftwareTechnology Services SimDesk Technologies, Inc. provided web based software solutions and services. Its software products were used for desktop applications such as word processing, spreadsheets, printing, and e-mail management. The firm offered services to the government agencies and educational institutions. The company was founded by Ray C. Davis in 1999 and was headquartered in Houston, TX. | Technology Services |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Health Technology |
Luson Bioventures LLC
Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Finance |
Kinagen, Inc. | |
Assembly Pharmaceuticals, Inc.
Assembly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Assembly Pharmaceuticals, Inc. manufactures and supplies biopharmaceutical products. The company was founded on August 8, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Gate Neurosciences, Inc.
Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Health Technology |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Finance |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Health Technology |
Anagin, Inc.
Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Health Technology |
- Börse
- Insiders
- Derek Small
- Erfahrung